FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * DST Capital LLC 2. Issuer Name and Ticker or Trading Symbol Biostage, Inc. [ BSTG ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, SUITE 11
3. Date of Earliest Transaction (MM/DD/YYYY)
3/9/2020
(Street)
HOLLISTON, MA 01746
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant (right to buy)  $2  3/9/2020    J (1)       51500   12/27/2017  12/27/2022  Common Stock  51500  $0  307000  D   
Warrant (right to buy)  $2  3/20/2020    J (1)       100000   12/27/2017  12/27/2022  Common Stock  100000  $0  207000  D   
Warrant (right to buy)  $2  9/11/2020    J (1)       100000   12/27/2017  12/27/2022  Common Stock  100000  $0  107000  D   
Warrant (right to buy)  $2  9/11/2020    J (1)       100000   12/27/2017  12/27/2022  Common Stock  100000  $0  7000  D   

Explanation of Responses:
(1)  These warrants were transferred by the Reporting Person on the condition that the assignee immediately exercise the Warrants for cash.

Remarks:
This form has been signed under power of attorney.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
DST Capital LLC
C/O BIOSTAGE, INC.
84 OCTOBER HILL ROAD, SUITE 11
HOLLISTON, MA 01746

X


Signatures
/s/ Chad Porter, by power of attorney 9/15/2020
**Signature of Reporting Person Date
Biostage (QB) (USOTC:BSTG)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more Biostage (QB) Charts.
Biostage (QB) (USOTC:BSTG)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more Biostage (QB) Charts.